PubMed

Experiences of a long-term randomized controlled prevention trial in a maiden environment: Estonian Postmenopausal Hormone Therapy trial.

Hovi SL, Veerus P, Rahu M, Hemminki E.

BMC Med Res Methodol. 2008 Aug 1;8:51.PMID: 18673555 [PubMed - indexed for MEDLINE]Related articlesFree article

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators.

JAMA. 2002 Jul 17;288(3):321-33.PMID: 12117397 [PubMed - indexed for MEDLINE]Related articlesFree article

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J; WHIMS Investigators.

JAMA. 2003 May 28;289(20):2651-62.PMID: 12771112 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D; WHIMS Investigators.

JAMA. 2003 May 28;289(20):2663-72.PMID: 12771113 [PubMed - indexed for MEDLINE]Related articlesFree article

The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.

Lemay A.

J Obstet Gynaecol Can. 2002 Sep;24(9):711-5.PMID: 12360366 [PubMed - indexed for MEDLINE]Related articles

Recent epidemiological evidence relevant to the clinical management of the menopause.

Shapiro S.

Climacteric. 2007 Oct;10 Suppl 2:2-15. Review.PMID: 17882666 [PubMed - indexed for MEDLINE]Related articles

Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies.

Shapiro S.

Climacteric. 2006 Dec;9(6):416-20.PMID: 17085373 [PubMed - indexed for MEDLINE]Related articles

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.

Vickers MR, MacLennan AH, Lawton B, Ford D, Martin J, Meredith SK, DeStavola BL, Rose S, Dowell A, Wilkes HC, Darbyshire JH, Meade TW; WISDOM group.

BMJ. 2007 Aug 4;335(7613):239. Epub 2007 Jul 11.PMID: 17626056 [PubMed - indexed for MEDLINE]Related articlesFree article

[Clinical study of the month. Benefit/risk balance of postmenopausal estrogen-progestin treatment in peril in the Women's Health Initiative study: practical attitude of the clinician]

Gaspard U, van den Brûle F, Pintiaux A, Foidart JM.

Rev Med Liege. 2002 Aug;57(8):556-62. Review. French. PMID: 12405030 [PubMed - indexed for MEDLINE]Related articles

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E.

JAMA. 1998 Aug 19;280(7):605-13.PMID: 9718051 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S; Women's Health Initiative Steering Committee.

JAMA. 2004 Apr 14;291(14):1701-12.PMID: 15082697 [PubMed - indexed for MEDLINE]Related articlesFree article

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.

Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J, Brzyski R, Allison M, Ockene J, Sarto G, Rossouw JE.

Am J Epidemiol. 2009 Jul 1;170(1):12-23. Epub 2009 May 25.PMID: 19468079 [PubMed - indexed for MEDLINE]Related articles

Who wants to join preventive trials?--Experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757].

Hovi SL, Hakama M, Veerus P, Rahu M, Hemminki E.

BMC Med Res Methodol. 2005 Apr 12;5(1):12.PMID: 15826311 [PubMed - indexed for MEDLINE]Related articlesFree article

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C.

Maturitas. 2006 Sep 20;55(2):103-15. Epub 2006 Jul 11.PMID: 16815651 [PubMed - indexed for MEDLINE]Related articles

Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.

Kang BM, Kim MR, Park HM, Yoon BK, Lee BS, Chung HW, Cho SH, Choi H, Kim JG.

Menopause. 2006 Jan-Feb;13(1):125-9.PMID: 16607108 [PubMed - indexed for MEDLINE]Related articles

Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.

Burger H.

Climacteric. 2003 May;6 Suppl 1:11-36. Review.PMID: 12945798 [PubMed - indexed for MEDLINE]Related articles

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB; Women's Health Initiative Investigators.

JAMA. 2003 Oct 1;290(13):1729-38.PMID: 14519707 [PubMed - indexed for MEDLINE]Related articlesFree article

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.PMID: 17882669 [PubMed - indexed for MEDLINE]Related articles

Use and perception of hormone therapy following media reports of the Women's Health Initiative: a survey of Australian WISDOM participants.

Paine BJ, Stocks NP, Ramsay EN, Ryan P, MacLennan AH; WISDOM Australia Research team.

Climacteric. 2004 Jun;7(2):143-52.PMID: 15497903 [PubMed - indexed for MEDLINE]Related articles

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH; Women's Health Initiative Memory Study.

JAMA. 2004 Jun 23;291(24):2947-58.PMID: 15213206 [PubMed - indexed for MEDLINE]Related articlesFree article